AzTrials
AzTrials

Obsessive-Compulsive Disorder in AdolescenceNCT06033391

Mobile App for Obsessive-compulsive Disorder in Adolescents

A study testing GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) and GGN-AD (GG Neutral - Adolescents) in people with Obsessive-Compulsive Disorder in Adolescence, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study is to assess the efficacy of the module GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) in reducing obsessive-compulsive disorder (OCD) related maladaptive beliefs and OCD symptoms in adolescents from 15 to 18 years old. Read more about this study

Who is it for?
Ages 15 to 17 yearsHealthy volunteers can take part
What is being tested?
GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) and GGN-AD (GG Neutral - Adolescents)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
1 siteSpain
Study dates
9 Apr 2024to 24 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • To have signed the informed consent, both the adolescents and their parents or legal guardians.
  • Being enrolled in 4th level of Obligatory Secondary Education of the Spanish Education System (ISCED levels 2 and 3 in the International Standard Classification of Education)
  • To have a mobile phone (indistinctly Android or iOS mobile system) with Internet access.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Spain1 site

  • University of Valencia/ Universitat de València

    Valencia, 46010

Other trials in Spain

About this study

Official title: Promoting Mental Health in Adolescents Through Mobile Apps: the Case of Obsessive-compulsive Disorder

The aim of the present study is to assess the efficacy of the module GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) in reducing obsessive-compulsive disorder (OCD) related maladaptive beliefs and OCD symptoms in adolescents from 15 to 18 years old. Specifically, a randomized controlled trial with two conditions (experimental and control) will be carried out in a non-clinical adolescent population to assess pre-post-intervention changes. After 14 days of using GGOC-AD, it is expected, primarily, to find a decrease in OCD-related maladaptive beliefs and OCD symptoms. As secondary results, we do not expect changes in emotional symptomatology, but we do expect an increase in self-esteem. Additionally, these changes are expected to be found in a one-month follow-up.

Read the detailed description

Pediatric OCD is a serious problem and, if not treated early on, is associated with significant impairment. The app GGOC, aimed at working on OCD-related dysfunctional beliefs in adults, has proven in previous studies in adult clinical and non-clinical samples, to significantly decrease maladaptive beliefs associated with OCD and obsessive-compulsive symptomatology. Also, it can significantly increase self-esteem. Therefore, it is relevant to adapt the GGOC application to the adolescent population (GGOC-AD) and evaluate its effectiveness.

Being tested
GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents), GGN-AD (GG Neutral - Adolescents)
Keywords
obsessive-compulsive disorder, cognitive therapy, maladaptive beliefs, mobile app, adolescence
Medical subject headings
Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents)Device

    GGOC was originally designed to challenge maladaptive beliefs that underline OCD symptoms in adult population. It was adapted to adolescent population. It consists of statements that are presented to the user, and that can portray either negative ("I can't trust myself") or positive beliefs ("I have a lot of good characteristics"). Users have to respond by either pulling these towards "Accept" or "Reject".

  • GGN-AD (GG Neutral - Adolescents)Device

    it was designed to have a comparison group. It consists of neutral statements such as "Madrid is a Spanish city", that ought not to produce changes in the direction of our hypothesis. These have to be "Accepted" or "Rejected" based on their veracity.

Study groups in NCT06033391
Study groupRoleWhat they receive
GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents)ExperimentalThe experimental group will use the GGOC-AD module for 14 days after the first assessment.
Receives: Device: GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents)
GGN-AD (GG Neutral - Adolescents)Active comparatorThe control group will use the GGN-AD module for 14 days after the first assessment.
Receives: Device: GGN-AD (GG Neutral - Adolescents)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in obsessive beliefs

    Score change in obsessive compulsive maladaptive beliefs measured by the Obsessive Beliefs Questionnaire-Child Version (OBQ-CV). Total score is computed as a mean of the 44 items, ranging from 0 "strongly disagree" to 4 "strongly agree". Higher scores indicate the person has more obsessive beliefs.

    Measured: Through app completion (14 days) and 1 month follow-up

  2. Change in obsessive-compulsive symptomatology

    Score change in obsessive-compulsive symptoms measured by the Obsessive Compulsive Inventory- Child Version (OCI-R-CV). Total score is computed as a mean of the 21 items, ranging from 0 "never" to 2 "always". Higher scores indicate a greater presence of obsessive-compulsive symptoms.

    Measured: Through app completion (14 days) and 1 month follow-up

Secondary outcomes (2)

  1. Change in emotional symptoms

    Change in depression and anxiety symptoms measured by The Patient Health Questionnaire for Depression and Anxiety (PH-4). It consists of 4 items, two for Anxiety and two for Depression, with a 4-point Likert scale (from 0 = "never" to 3 = "almost every day"). Higher scores indicate a greater presence of depression or anxiety symptoms.

    Measured: Through app completion (14 days) and 1 month follow-up

  2. Change in self-esteem

    Change in score of Single Item Self Esteem Scale (SISE). Self-Esteem is measured with this single item ranging from 1 "It is not very true for me" to 7 "It is very true for me". Higher scores indicate a higher self-esteem.

    Measured: Through app completion (14 days) and 1 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2023
  2. Study start9 Apr 2024
  3. Primary completion24 May 2024
  4. Study completion24 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants that meet the inclusion criteria will complete the web-based baseline assessment (pre), with questionnaires relating to maladaptive beliefs, mood (anxiety and depressions), self-esteem and OCD symptoms. After, experimental group will use the GGOC-AD, and control group will use the GGN-AD for 14 days. Then, both groups will complete again the above-mentioned assessment instruments (post use of the app). Finally, all participants will complete the follow-up measures at one month.
Masking
Single blind
Who is masked
Participant
Enrolment
94 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06033391
Sponsor's protocol ID
2557724
Status last verified
Dec 2025
First submitted
4 Sep 2023
Last updated
18 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Share all IPD that underlie results in a publication.

Publications

  • Roncero M, Belloch A, Doron G. Can Brief, Daily Training Using a Mobile App Help Change Maladaptive Beliefs? Crossover Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Feb 13;7(2):e11443. doi: 10.2196/11443.

    PubMed 30758294

  • Saman Y, Pascual-Vera B, Carrasco A, Corberan M, Merchan O, Carratala-Ricart L, Arnaez S, Doron G, Roncero M, Garcia-Soriano G. GGOC-AD: a mHealth tool to challenge obsessive-compulsive related maladaptive beliefs in Spanish community adolescents: a randomized controlled trial. Child Adolesc Ment Health. 2026 Jul 7. doi: 10.1111/camh.70110. Online ahead of print.

    PubMed 42415465

  • Saman Y, Pascual-Vera B, Corberan M, Arnaez S, Roncero M, Garcia-Soriano G. A mobile app to challenge obsessional beliefs in adolescents: a protocol of a two-armed, parallel randomized controlled trial. BMC Psychiatry. 2024 Apr 9;24(1):265. doi: 10.1186/s12888-024-05735-x.

    PubMed 38594680

Questions about this trial

What is this clinical trial studying?

A study testing GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) and GGN-AD (GG Neutral - Adolescents) in people with Obsessive-Compulsive Disorder in Adolescence, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in obsessive beliefs (time frame: Through app completion (14 days) and 1 month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06033391, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in